Literature DB >> 22587679

Iron oxide/hydroxide nanoparticles with negatively charged shells show increased uptake in Caco-2 cells.

Markus R Jahn1, Thomas Nawroth, Sören Fütterer, Uwe Wolfrum, Ute Kolb, Peter Langguth.   

Abstract

The absorption of commonly used ferrous iron salts from intestinal segments at neutral to slightly alkaline pH is low, mainly because soluble ferrous iron is easily oxidized to poorly soluble ferric iron and because ferrous iron, but not ferric iron, is carried by the divalent metal transporter DMT-1. Moreover, ferrous iron frequently causes gastrointestinal side effects. Iron hydroxide nanoparticles with neutral and hydrophilic carbohydrate shells are alternatively used to ferrous salts. In these formulations gastrointestinal side effects are rare because hundreds of ferric iron atoms are safely packed in nanoscaled cores surrounded by the solubilizing shell; nevertheless, iron bioavailability is even worse compared to ferrous salts. In this study the cell uptake of iron hydroxide and iron oxide nanoparticles (FeONP) with negatively charged shells of different chemical types and sizes was compared to the uptake of those with neutral hydrophilic shells, ferrous sulfate and ferric chloride. The nanoparticle uptake was measured in Caco-2 cells with the iron detecting ferrozine method and visualized by transmission electron microscopy. The toxicity was evaluated using the MTT assay. For nanoparticles with a negatively charged shell the iron uptake was about 40 times higher compared to those with neutral hydrophilic carbohydrate shell or ferric chloride and in the same range as ferrous sulfate. However, in contrast to ferrous sulfate, nanoparticles with negatively charged shells showed no toxicity. Two different uptake mechanisms were proposed: diffusion for hydroxide nanoparticles with neutral hydrophilic shell and adsorptive endocytosis for nanoparticles with negatively charged shells. It needs to be determined whether iron hydroxide nanoparticles with negatively charged shells also show improved bioavailability in iron-deficient patients compared to iron hydroxide nanoparticles with a neutral hydrophilic shell, which exist in the market today.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22587679     DOI: 10.1021/mp200628u

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  8 in total

1.  The Role of Metal Oxide Nanoparticles, Escherichia coli, and Lactobacillus rhamnosus on Small Intestinal Enzyme Activity.

Authors:  Alba García-Rodríguez; Fabiola Moreno-Olivas; Ricard Marcos; Elad Tako; Cláudia N H Marques; Gretchen J Mahler
Journal:  Environ Sci Nano       Date:  2020-11-09

2.  Magnetite nanoparticles coated with oleic acid: accumulation in hepatopancreatic cells of the mangrove crab Ucides cordatus.

Authors:  Hector Aguilar Vitorino; Priscila Ortega; Roxana Y Pastrana Alta; Flavia Pinheiro Zanotto; Breno Pannia Espósito
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-24       Impact factor: 4.223

Review 3.  Modern iron replacement therapy: clinical and pathophysiological insights.

Authors:  Domenico Girelli; Sara Ugolini; Fabiana Busti; Giacomo Marchi; Annalisa Castagna
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

4.  A nanoparticulate ferritin-core mimetic is well taken up by HuTu 80 duodenal cells and its absorption in mice is regulated by body iron.

Authors:  Gladys O Latunde-Dada; Dora I A Pereira; Bethan Tempest; Hibah Ilyas; Angela C Flynn; Mohamad F Aslam; Robert J Simpson; Jonathan J Powell
Journal:  J Nutr       Date:  2014-10-23       Impact factor: 4.798

5.  Mechanisms of Iron Uptake from Ferric Phosphate Nanoparticles in Human Intestinal Caco-2 Cells.

Authors:  Antonio Perfecto; Christine Elgy; Eugenia Valsami-Jones; Paul Sharp; Florentine Hilty; Susan Fairweather-Tait
Journal:  Nutrients       Date:  2017-04-04       Impact factor: 5.717

6.  Receptor-mediated endocytosis and brain delivery of therapeutic biologics.

Authors:  Guangqing Xiao; Liang-Shang Gan
Journal:  Int J Cell Biol       Date:  2013-06-11

7.  Evaluating the potential of cubosomal nanoparticles for oral delivery of amphotericin B in treating fungal infection.

Authors:  Zhiwen Yang; Meiwan Chen; Muhua Yang; Jian Chen; Weijun Fang; Ping Xu
Journal:  Int J Nanomedicine       Date:  2014-01-06

Review 8.  Tailoring Iron Oxide Nanoparticles for Efficient Cellular Internalization and Endosomal Escape.

Authors:  Laura Rueda-Gensini; Javier Cifuentes; Maria Claudia Castellanos; Paola Ruiz Puentes; Julian A Serna; Carolina Muñoz-Camargo; Juan C Cruz
Journal:  Nanomaterials (Basel)       Date:  2020-09-11       Impact factor: 5.076

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.